Oramed Pharmaceuticals Inc. Common Stock (NASDAQ: ORMP) last traded at $4.81, up 0.42% on the session. The quote above updates while this page is open; the figures below are drawn from Oramed Pharmaceuticals Inc. Common Stock’s own filings and are restated only when a new one is published.
Oramed Pharmaceuticals Inc. Common Stock trades on NASDAQ under the ticker ORMP. Its market capitalisation is $200.08 million.
Valuation measures for Oramed Pharmaceuticals Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $200.08M |
|---|---|
| P/E ratio | 1.16 |
| Price / sales | 100.04 |
| Price / book | 1.00 |
| Beta | 1.14 |
Trailing-twelve-month figures tagged in Oramed Pharmaceuticals Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $2.00M |
|---|---|
| Net income (TTM) | $174.87M |
| EPS (TTM) | $4.13 |
| Gross margin | 0.65% |
| Operating margin | -726.20% |
| Return on equity | 87.55% |
| Cash | $15.24M |
Range and volume for ORMP over the past 52 weeks.
| 52-week high | $5.19 |
|---|---|
| 52-week low | $2.09 |
| Volume | 124.5K |
| Average volume | 295.0K |
| Previous close | $4.79 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.